Nanexa AB (publ) announced that the company has been granted a patent in India relating to its PharmaShell technology. This patent covers the relevant manufacturing method, coated drug particles that result therefrom, and pharmaceutical composition containing those particles. The PharmaShell patent is already granted in the US, Japan, Korea, China, Canada and in European countries.

With the approval in India, Nanexa now has patents in all countries where it applied for patent protection.